Atlas Trials

Jinming Yu

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Jinming Yu

RecordFirmDate
Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC (NCT06672133)Jinming Yu2024-12-01
The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer (NCT06483919)Jinming Yu2023-10-01
Real-World Study of Iruplinalkib in the Treatment of ALK-Positive Non-Small Cell Lung Cancer (NCT05991895)Jinming Yu2023-07-24
A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and Chemotherapy (NCT05942508)Jinming Yu2023-05-30
WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC (NCT05351320)Jinming Yu2022-04-30
A Phase Ⅱ Trial of Pyrotinib Combination With CDK4/6 Inhibitor SHR6390 in Patients Prior Trastuzumab-treated Advanced HER2-Positive Breast Cancer (NCT04095390)Jinming Yu2019-09-30

Track Jinming Yu automatically

Every clearance here is in the API, with alerts when new ones post.